Literature DB >> 21907252

Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity.

R Noelle Palumbo1, Xiao Zhong, Chun Wang.   

Abstract

Direct targeting of dendritic cells is an ideal goal for DNA vaccine delivery in order to stimulate both arms of the immune system. However, dendritic cells are often difficult to transfect using nonviral polyplexes. Here we show that transfecting bystander cells such as fibroblasts with PEI/DNA compn>lexes leads to efficient cross-presentation of a model antigen by dendritic cells and subsequent activation of antigen-sn>an class="Chemical">pecific CD8(+) T cells. Maturation of dendritic cells is also stimulated after co-culture with transfected fibroblasts. Such outcomes depend on a proper balance between transfection efficiency and polyplex-induced cytotoxicity in the fibroblasts. In fact, substantial cytotoxicity is desirable and even necessary for cross-presentation and cross-priming of T cells. This study illustrates a new pathway of polymer-based DNA vaccine delivery via bystander cells without direct targeting of antigen-presenting cells and highlights the importance of exploiting polymer-induced cytotoxicity for the benefit of immune activation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907252      PMCID: PMC3260377          DOI: 10.1016/j.jconrel.2011.08.037

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  40 in total

1.  Cationic microparticles: A potent delivery system for DNA vaccines.

Authors:  M Singh; M Briones; G Ott; D O'Hagan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses.

Authors:  Y Shi; W Zheng; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 3.  Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines.

Authors:  B K Coombes; J B Mahony
Journal:  Immunol Lett       Date:  2001-09-03       Impact factor: 3.685

4.  Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens.

Authors:  Yan Shi; Kenneth L Rock
Journal:  Eur J Immunol       Date:  2002-01       Impact factor: 5.532

Review 5.  Targeting vaccines to dendritic cells.

Authors:  Camilla Foged; Anne Sundblad; Lars Hovgaard
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

6.  Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization.

Authors:  J H Cho; J W Youn; Y C Sung
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells.

Authors:  D Arnold-Schild; D Hanau; D Spehner; C Schmid; H G Rammensee; H de la Salle; H Schild
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

9.  Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies.

Authors:  Tae Woo Kim; Chien-Fu Hung; David Boyd; Jeremy Juang; Liangmei He; Jeong Won Kim; J Marie Hardwick; T-C Wu
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

10.  Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.

Authors:  Yoshiyuki Hattori; Shigeru Kawakami; Sachiko Suzuki; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Biochem Biophys Res Commun       Date:  2004-05-14       Impact factor: 3.575

View more
  7 in total

1.  Poly(2-aminoethyl methacrylate) with well-defined chain length for DNA vaccine delivery to dendritic cells.

Authors:  Weihang Ji; David Panus; R Noelle Palumbo; Rupei Tang; Chun Wang
Journal:  Biomacromolecules       Date:  2011-11-16       Impact factor: 6.988

Review 2.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

Review 3.  Polyethylenimine-based micro/nanoparticles as vaccine adjuvants.

Authors:  Chen Shen; Jun Li; Yi Zhang; Yuce Li; Guanxin Shen; Jintao Zhu; Juan Tao
Journal:  Int J Nanomedicine       Date:  2017-07-31

4.  Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy.

Authors:  Jutaek Nam; Sejin Son; Kyung Soo Park; James J Moon
Journal:  Adv Sci (Weinh)       Date:  2021-01-06       Impact factor: 16.806

5.  Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes.

Authors:  Liulin Chen; Junming Zhu; Yuhong Li; Jie Lu; Li Gao; Huibi Xu; Mingwen Fan; Xiangliang Yang
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

6.  Antitumor cell-complex vaccines employing genetically modified tumor cells and fibroblasts.

Authors:  Antonio Miguel; María José Herrero; Luis Sendra; Rafael Botella; Ana Diaz; Rosa Algás; Salvador F Aliño
Journal:  Toxins (Basel)       Date:  2014-02-19       Impact factor: 4.546

7.  Systematically probing the bottom-up synthesis of AuPAMAM conjugates for enhanced transfection efficiency.

Authors:  Elizabeth R Figueroa; J Stephen Yan; Nicolette K Chamberlain-Simon; Adam Y Lin; Aaron E Foster; Rebekah A Drezek
Journal:  J Nanobiotechnology       Date:  2016-03-31       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.